Improving neuroblastoma therapy by targeting intra-tumoral hypoxia and immune checkpoint axis PD-1/PD-L1

Reference : Improving neuroblastoma therapy by targeting intra-tumoral hypoxia and immune checkpo...


	Document type :	Dissertations and theses : Doctoral thesis
	Discipline(s) :	Human health sciences : Oncology Human health sciences : Pediatrics
	To cite this reference:	http://hdl.handle.net/10993/54426

Title :	Improving neuroblastoma therapy by targeting intra-tumoral hypoxia and immune checkpoint axis PD-1/PD-L1
Language :	English
Author, co-author :	Sauvage, Delphine [University of Luxembourg > Faculty of Science, Technology and Medecine (FSTM) > >]
Publication date :	23-Sep-2022
Institution :	University of Luxembourg, Luxembourg
Name of the degree :	Docteur en Biologie
Number of pages :	145
Supervisor :	Janji, Bassam
President of the jury :	Haan, Serge
Member of the jury :	Berchem, Guy Joseph Maximilien Jean
	Khaled, Mehdi
	Krayem, Mohammad
Keywords :	[en] neuroblastoma ; immune checkpoint inhibitors ; PD-1/PD-L1 ; immunotherapy ; hypoxia ; epigenetic drugs ; JQ1 ; combinatorial therapy ; tumor vasculature
Research centres :	Luxembourg Institute of Health - LIH
Permalink :	http://hdl.handle.net/10993/54426

File(s) associated to this reference

Fulltext file(s):

	File	Commentary	Version	Size	Access
Open access	Improving neuroblastoma therapy by targeting intra-tumoral hypoxia and immune checkpoint axis PD-1:PD-L1.pdf		Author preprint	21.19 MB	View/Open

All documents in ORBi^lu are protected by a user license.